Age-Related Metabolic Profiles in Cognitively Healthy Elders: Results from a Voxel-Based [¹⁸F]Fluorodeoxyglucose–Positron-Emission Tomography Study with Partial Volume Effects Correction

References

1. 1.↵
   1. Small GW,
   2. Bookheimer SY,
   3. Thompson PM,
   4. et al

   . Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol 2008;7:161–72

   CrossRefPubMedWeb of Science
2. 2.↵
   1. de Leon MJ,
   2. George AE,
   3. Ferris SH,
   4. et al

   . Positron emission tomography and computed tomography assessments of the aging human brain. J Comput Assist Tomogr 1984;8:88–94

   PubMedWeb of Science
3. 3.↵
   1. de Leon MJ,
   2. George AE,
   3. Tomanelli J,
   4. et al

   . Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET VI and 11-CDG. Neurobiol Aging 1987;8:319–23

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Duara R,
   2. Margolin RA,
   3. Robertson-Tchabo EA,
   4. et al

   . Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain 1983;106(pt 3):761–75

   Abstract/FREE Full Text
5. 5.↵
   1. Rapoport SI,
   2. Duara R,
   3. Haxby JV

   . Positron emission tomography in normal aging and Alzheimer's disease. Psychopharmacol Bull 1984;20:466–71

   PubMed
6. 6.↵
   1. Schlageter NL,
   2. Horwitz B,
   3. Creasey H,
   4. et al

   . Relation of measured brain glucose utilisation and cerebral atrophy in man. J Neurol Neurosurg Psychiatry 1987;50:779–85

   Abstract/FREE Full Text
7. 7.↵
   1. Fujimoto T,
   2. Matsumoto T,
   3. Fujita S,
   4. et al

   . Changes in glucose metabolism due to aging and gender-related differences in the healthy human brain. Psychiatry Res 2008;164:58–72

   CrossRefPubMed
8. 8.↵
   1. Kalpouzos G,
   2. Chetelat G,
   3. Baron JC,
   4. et al

   . Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 2009;30:112–24

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Moeller JR,
   2. Ishikawa T,
   3. Dhawan V,
   4. et al

   . The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996;16:385–98

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Willis MW,
    2. Ketter TA,
    3. Kimbrell TA,
    4. et al

    . Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Res 2002;114:23–37

    PubMedWeb of Science
11. 11.↵
    1. Petit-Taboue MC,
    2. Landeau B,
    3. Desson JF,
    4. et al

    . Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 1998;7:176–84

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Yanase D,
    2. Matsunari I,
    3. Yajima K,
    4. et al

    . Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging 2005;32:794–805

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Townsend DW

    . Positron emission tomography/computed tomography. Semin Nucl Med 2008;38:152–66

    CrossRefPubMed
14. 14.↵
    1. Ashburner J

    . Computational anatomy with the SPM software. Magn Reson Imaging 2009;27:1163–74. Epub 2009 Feb 27

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Kochunov P,
    2. Ramage AE,
    3. Lancaster JL,
    4. et al

    . Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage 2009;45:17–28

    CrossRefPubMed
16. 16.↵
    1. Meltzer CC,
    2. Cantwell MN,
    3. Greer PJ,
    4. et al

    . Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med 2000;41:1842–48

    Abstract/FREE Full Text
17. 17.↵
    1. Aston JA,
    2. Cunningham VJ,
    3. Asselin MC,
    4. et al

    . Positron emission tomography partial volume correction: estimation and algorithms. J Cereb Blood Flow Metab 2002;22:1019–34

    PubMedWeb of Science
18. 18.↵
    1. Ibanez V,
    2. Pietrini P,
    3. Alexander GE,
    4. et al

    . Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998;50:1585–93

    Abstract/FREE Full Text
19. 19.↵
    1. Mosconi L,
    2. Sorbi S,
    3. de Leon MJ,
    4. et al

    . Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006;47:1778–86

    Abstract/FREE Full Text
20. 20.↵
    1. Fouquet M,
    2. Desgranges B,
    3. Landeau B,
    4. et al

    . Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain 2009;132:2058–67

    Abstract/FREE Full Text
21. 21.↵
    1. Mevel K,
    2. Desgranges B,
    3. Baron JC,
    4. et al

    . Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. Neuroimage 2007;37:18–25

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Samuraki M,
    2. Matsunari I,
    3. Chen WP,
    4. et al

    . Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur J Nucl Med Mol Imaging 2007;34:1658–69

    CrossRefPubMed
23. 23.↵
    1. Scazufca M,
    2. Menezes PR,
    3. Vallada HP,
    4. et al

    . High prevalence of dementia among older adults from poor socioeconomic backgrounds in Sao Paulo, Brazil. Int Psychogeriatr 2008;20:394–405

    PubMed
24. 24.↵
    1. Scazufca M,
    2. Seabra CA

    . Sao Paulo portraits: ageing in a large metropolis. Int J Epidemiol 2008;37:721–23. Epub 2007 Jul 31

    FREE Full Text
25. 25.↵
    1. Hamilton M

    . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–96

    CrossRefPubMed
26. 26.↵
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994
27. 27.↵
    1. Prince M,
    2. Ferri CP,
    3. Acosta D,
    4. et al

    . The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health 2007;7:165

    CrossRefPubMed
28. 28.↵
    1. Hall KS,
    2. Gao S,
    3. Emsley CL,
    4. et al

    . Community screening interview for dementia (CSI ‘D'): performance in five disparate study sites. Int J Geriatr Psychiatry 2000;15:521–31

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Ganguli M,
    2. Chandra V,
    3. Gilby JE,
    4. et al

    . Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study. Int Psychogeriatr 1996;8:507–24

    CrossRefPubMed
30. 30.↵
    1. Copeland JR,
    2. Prince M,
    3. Wilson KC,
    4. et al

    . The Geriatric Mental State Examination in the 21st century. Int J Geriatr Psychiatry 2002;17:729–32

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Wilson PW,
    2. D'Agostino RB,
    3. Levy D,
    4. et al

    . Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47

    Abstract/FREE Full Text
32. 32.↵
    1. Razay G,
    2. Vreugdenhil A,
    3. Wilcock G

    . The metabolic syndrome and Alzheimer disease. Arch Neurol 2007;64:93–96

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Faul F,
    2. Erdfelder E,
    3. Lang AG,
    4. et al

    . G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–91

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Ashburner J

    . A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113. Epub 2007 Jul 18

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Klein A,
    2. Andersson J,
    3. Ardekani BA,
    4. et al

    . Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 2009;46:786–802

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Yassa MA,
    2. Stark CE

    . A quantitative evaluation of cross-participant registration techniques for MRI studies of the medial temporal lobe. Neuroimage 2009;44:319–27

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Mazziotta JC,
    2. Toga AW,
    3. Evans A,
    4. et al

    . A probabilistic atlas of the human brain: theory and rationale for its development—The International Consortium for Brain Mapping (ICBM). Neuroimage 1995;2:89–101

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Quarantelli M,
    2. Berkouk K,
    3. Prinster A,
    4. et al

    . Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 2004;45:192–201

    Abstract/FREE Full Text
39. 39.↵
    1. Reiman EM,
    2. Chen K,
    3. Langbaum JB,
    4. et al

    . Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage 2010;49:169–76. Epub 2009 Jul 23

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Rimajova M,
    2. Lenzo NP,
    3. Wu JS,
    4. et al

    . Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population. J Alzheimers Dis 2008;13:137–46

    PubMedWeb of Science
41. 41.↵
    1. Kennedy KM,
    2. Erickson KI,
    3. Rodrigue KM,
    4. et al

    . Age-related differences in regional brain volumes: a comparison of optimized voxel-based morphometry to manual volumetry. Neurobiol Aging 2009;30:1657–76

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Friston KJ,
    2. Holmes AP,
    3. Worsley KJ,
    4. et al

    . Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1994;2:189–210

    CrossRef
43. 43.↵
    1. Curiati PK,
    2. Tamashiro JH,
    3. Squarzoni P,
    4. et al

    . Brain structural variability due to aging and gender in cognitively healthy elders: results from the Sao Paulo Ageing and Health study. AJNR Am J Neuroradiol 2009;30:1850–56. Epub 2009 Aug 6

    Abstract/FREE Full Text
44. 44.↵
    1. Mosconi L,
    2. De Santi S,
    3. Li J,
    4. et al

    . Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 2008;29:676–92

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Meltzer CC,
    2. Zubieta JK,
    3. Brandt J,
    4. et al

    . Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996;47:454–61

    Abstract/FREE Full Text
46. 46.↵
    1. Drzezga A,
    2. Grimmer T,
    3. Henriksen G,
    4. et al

    . Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage 2008;39:619–33

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Inoue K,
    2. Ito H,
    3. Goto R,
    4. et al

    . Apparent CBF decrease with normal aging due to partial volume effects: MR-based partial volume correction on CBF SPECT. Ann Nucl Med 2005;19:283–90

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Taki Y,
    2. Goto R,
    3. Evans A,
    4. et al

    . Voxel-based morphometry of human brain with age and cerebrovascular risk factors. Neurobiol Aging 2004;25:455–63

    CrossRefPubMedWeb of Science
49. 49.↵
    1. Raz N,
    2. Lindenberger U,
    3. Rodrigue KM,
    4. et al

    . Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 2005;15:1676–89

    Abstract/FREE Full Text
50. 50.
    1. Talairach J,
    2. Tornoux P

    . Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers. 1998